ADVFN Logo
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

INBX Inhibrx Inc

34.32
-0.13 (-0.38%)
Apr 19 2024 - Closed
Delayed by 15 minutes
Company Name Stock Ticker Symbol Market Type
Inhibrx Inc INBX NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.13 -0.38% 34.32 16:15:01
Open Price Low Price High Price Close Price Prev Close
34.40 34.2237 34.595 34.32 34.45
more quote information »

Recent News

Date Time Source Heading
3/11/202416:26EDGAR2Form 144 - Report of proposed sale of securities
3/08/202416:08EDGAR2Form 144 - Report of proposed sale of securities
3/08/202415:28EDGAR2Form 144 - Report of proposed sale of securities
3/06/202416:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/05/202414:58EDGAR2Form 144 - Report of proposed sale of securities
3/04/202418:26EDGAR2Form 144 - Report of proposed sale of securities
2/29/202417:26EDGAR2Form PREM14A - Preliminary proxy statements relating to..
2/28/202409:15PRNUSInhibrx Reports Fourth Quarter and Fiscal Year 2023..
2/28/202409:12EDGAR2Form 8-K - Current report
2/28/202409:10EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
2/14/202416:12EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2/06/202416:30EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
1/26/202412:12PRNUSKuehn Law Encourages DOC, BATL, KAMN, and INBX Investors to..
1/23/202417:25EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
1/23/202406:38EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
1/23/202406:35EDGAR2Form 8-K - Current report
1/23/202406:05DJNSanofi to Buy Assets From Inhibrx in Deal Valued at Up to..
1/23/202405:40IHMARKETNEWSWall Street Highlights: Vroom Shuts Down Online Car Sales,..
1/23/202401:00PRNUSInhibrx Announces Sale of INBRX-101 to Sanofi for an..
11/09/202316:03EDGAR2Form 8-K - Current report
11/09/202316:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/09/202316:00PRNUSInhibrx Reports Third Quarter 2023 Financial Results and..
11/02/202309:16EDGAR2Form 8-K - Current report
11/02/202309:15PRNUSInhibrx Announces Preliminary Data from the Phase 1 Trial of..
10/18/202316:00PRNUSInhibrx Announces Participation in Upcoming Scientific..
9/19/202316:03EDGAR2Form 8-K - Current report
9/19/202316:00PRNUSInhibrx Retains Rights to INBRX-101 for the Treatment of..
8/31/202316:06EDGAR2Form D - Notice of Exempt Offering of Securities
8/29/202309:03EDGAR2Form 8-K - Current report
8/29/202309:00PRNUSInhibrx Announces $200 Million Private Placement Financing
8/07/202316:03EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/07/202316:00PRNUSInhibrx Reports Second Quarter 2023 Financial Results and..
5/30/202309:46DJNInhibrx Granted FDA Fast Track Designation for INBRX-101
5/30/202309:00PRNUSInhibrx Granted Fast Track Designation for INBRX-101 for the..
5/08/202316:05PRNUSInhibrx Reports First Quarter 2023 Financial Results and..
4/26/202309:00PRNUSInhibrx Initiates a Registration-Enabling Trial of INBRX-101..

Your Recent History

Delayed Upgrade Clock